Researchers at the National Cancer Center (NCC) have identified new bile duct cancer subtypes by analyzing proteogenomic data to reveal new therapeutic targets for intractable intrahepatic bile duct cancer, the hospital said.Protein genome research is in the spotlight as a research method that can o
SK Plasma said it will begin the construction of its new blood product plant in Indonesia, which will be able to manufacture a million liters of plasma raw materials annually, in May.The company plans to complete the construction by 2025.The announcement follows the Indonesian authorities approving
Juvic, a microneedle drug developer, said on Friday that it has successfully developed a new patch-type diabetes treatment called an egg microneedle (EMN) to overcome the limitations of existing dissolvable microneedles (DMN).The research team led by Professors Jung Hyung-il of the Biotechnology Dep
Tertiary hospitals in Korea and clinics have invested a lot in IT systems to enhance the convenience and quality of medical services but individuals still lack access to managing their own health, noted Kakao Healthcare CEO Hwang Hee.Kakao, known for its strength as a tech company, will focus on mob
Medical Korea 2023 kicked off on Thursday designating Super Junior’s Kim Ryeowook as the Medical Charity Honorary Ambassador to promote Korea’s medical tourism at COEX.“I am honoured to get this appointment to spread this cause and raise awareness of Koreas medical services,” said Kim of the K-pop i
Researchers at the Institute of Basic Sciences (IBS) have successfully mapped blood and lymph vessels in the nasal cavity in three dimensions for the first time in the world, revealing key observations for improving mucosal immunity.The nose is both a sensory organ responsible for smell and the firs
Celltrion and Thermo Fisher are reportedly vying to acquire the biopharma solutions unit of Baxter International.According to Reuters, the sale could go up as high as $4 billion, which would help alleviate Baxter's debt burden. Baxter's debt is considerably high at $16.6 billion as of the end of Dec
Researchers at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) developed a bacterial cancer therapeutic that increases drug permeability in cancerous tissues when combined with chemotherapeutic drugs.Chemotherapy stops the growth of cancer cells which can be administered orally,
CHA University Bundang Medical Center (CBMC) said on Monday that its researchers proved the safety and effectiveness of dopamine neural precursor cells derived from fetal mesenchymal stem cells transplanted into patients with Parkinson's disease "for the first time in the world."Parkinson's disease
Following the Moon Jae-in government, the Yoon Suk Yeol administration also emphasizes the need to promote the bio-industry. Still, there is a shortage of workers who jump into this field, experts pointed out Friday.That and other issues were discussed during the “5th K-Life & Bio Forum” held at the
Samsung Biologics held a board of directors meeting on Friday and announced that it will invest 1.9 trillion won ($1.45 billion) to build Plant 5, its fifth biopharmaceutical contract manufacturing organization (CMO) plant in Songdo, Incheon.Plant 5 will be the first plant in Bio Campus 2 and will b
Researchers from Ajou University School of Medicine published a study demonstrating that it is safe to use attention deficit hyperactivity disorder (ADHD) medication and antidepressants together in adolescents.The research team led by professor Shin Yun-mi of psychiatry investigated 330,000 ADHD pat
The Korea Advanced Institute of Science and Technology (KAIST) said on Tuesday that its researchers have developed a clathrin assembly that can specifically deliver drugs to cancer cells for a wide variety of biomedical applications.Cancer is often difficult to treat because drug delivery systems th
Many Korean biopharmaceutical companies will participate in the “2023 BIO-Europe Spring” in Basel, Switzerland, from March 20-22. Attention is focused on whether the massive participation will be able to melt frozen bio-related investment sentiment at home and abroad.Multinational companies, includi
The biopharmaceutical industry expressed its intention to welcome the National Assembly’s move to include “bio-health” in the national strategic industry eligible for tax benefits.In a statement on Thursday, KoreaBIO said it warmly welcomed the revision bill proposed by 11 lawmakers, including Rep.
Korean biosimilar products are rapidly expanding their market share against original drugs in the local pharmaceutical sector.Initially, biosimilars failed to make a splash in the domestic market, unlike in Europe and the U.S., because biosimilar makers could not secure price competitiveness against
Speculations grow that the merger between Celltrion Group's major affiliates —Celltrion, Celltrion Healthcare, and Celltrion Pharm— will accelerate with the recently planned comeback of Seo Jung-jin, the honorary chairman of Celltrion Group.Industry watchers based their speculations on the group’s r
A joint research team at KAIST and Samsung Medical Center have found a new target protein, CEACAM1, which can improve immune anticancer therapies through selective removal of T-cells found in tumors.The study identified a new target protein CEACAM1 that enables the selective removal of regulatory T
Seo Jung-jin, honorary chairman of Celltrion Group, will return to management after leaving the company two years ago to start anew as a startup entrepreneur.Celltrion Group's major affiliates – Celltrion Holdings, Celltrion, Celltrion Healthcare, and Celltrion Pharma – held separate board meetings
Samsung Biologics said in a public filing on Thursday that it signed a contract manufacturing organization (CMO) deal with Pfizer worth $183 million (241 billion won), which is equivalent to 15.37 percent of total sales in 2021.The contract period is from February 20, 2023, to December 31, 2029. How